SCHEMBL9158568

SCHEMBL9158568

Cn1c(=O)c2nc(-c3ccc(/C=C/C(=O)O)cc3)[nH]c2n(C)c1=S

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 8/20 0.52
▸ ADORA3 P0DMS8 6/20 0.52
▸ ADORA2A P29274 4/20 0.52
▸ ADORA1 P30542 4/20 0.52
▸ PTPN1 P18031 1/20 0.46
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DHODH Q02127 4/20 0.36
▸ CA12 O43570 1/20 0.35
▸ AKR1B10 O60218 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ CA3 P07451 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ TYR P14679 1/20 0.35
▸ AKR1B1 P15121 1/20 0.35
▸ CA4 P22748 1/20 0.35
▸ CA6 P23280 1/20 0.35
▸ DPP4 P27487 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6554063 0.90 ADORA2B (0.55) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL6554060 0.90 ADORA2B (0.55) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9153726 0.83 ADORA2B (0.54) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9153738 0.83 ADORA2B (0.54) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9158550 0.83 ADORA2B (0.58) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9158534 0.83 ADORA2B (0.58) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9159455 0.82 ADORA2B (0.66) ADORA2BADORA3ADORA2AADORA1PTPN1
SCHEMBL9152046 0.82 ADORA2B (0.68) ADORA2BADORA3ADORA2AADORA1MEN1
SCHEMBL9152034 0.82 ADORA2B (0.68) ADORA2BADORA3ADORA2AADORA1MEN1
SCHEMBL9159465 0.82 ADORA2B (0.66) ADORA2BADORA3ADORA2AADORA1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639055-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1995-02-22 — — EP claimed
WO-1993021783-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1993-11-11 — — WO claimed
US-4879296-A BLOCKING ADERNOSINE CELL SURFACE EFFECTS BURROUGHS WELLCOME CO. (US) 1989-11-07 — — US claimed
EP-0203721-A2 8-Phenyl xanthines THE WELLCOME FOUNDATION LIMITED (GB) 1986-12-03 — — EP claimed
EP-0639055-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1995-02-22 — — EP disclosed
US-5300298-A Methods of treating obesity with purine related compounds THE PENNSYLVANIA RESEARCH CORPORATION (US) 1994-04-05 — — US disclosed
WO-1993021783-A1 METHODS OF TREATING OBESITY WITH PURINE RELATED COMPOUNDS THE PENN STATE RESEARCH FOUNDATION (US) 1993-11-11 — — WO disclosed
EP-0203721-B1 8-PHENYL XANTHINES THE WELLCOME FOUNDATION LIMITED (GB) 1992-06-10 — — EP disclosed
US-5017577-A Using Purine Cinnamic Acids BURROUGHS WELLCOME CO. (US) 1991-05-21 — — US disclosed
US-5015647-A Using Purine Cinnamic Acid Compounds BURROUGHS WELLCOME CO. (US) 1991-05-14 — — US disclosed
US-4981857-A ADENOSINE ANTAGONIST BURROUGHS WELLCOME CO. (US) 1991-01-01 — — US disclosed
US-4879296-A BLOCKING ADERNOSINE CELL SURFACE EFFECTS BURROUGHS WELLCOME CO. (US) 1989-11-07 — — US disclosed
EP-0203721-A2 8-Phenyl xanthines THE WELLCOME FOUNDATION LIMITED (GB) 1986-12-03 — — EP disclosed
Send feedback